miami semaglutide class action Ozempic Lawsuit: July 2026 Blindness and Gastroparesis Claims Novo Nordisk settles with Florida

VK2735 VK2735 is an advanced dual GIP/GLP-1 receptor agonist with promising efficacy and the potential to become a major competitor in the injectable obesity market

Book a telehealth visit with PlushCare to see if you're eligible.

Season chicken

The approval of generic liraglutide is expected to make GLP-1 medications more accessible to patients who may not have been able to afford them otherwise and may offer a more affordable option for patients, potentially increasing adherence to treatment and improving weight loss outcomes and treatment maintenance

PlexusDx helps contextualize these factors through precision testing and provider-guided transitions